LAUSR

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, normally meets 3 times per year to develop recommendations for vaccine use in the U.S. Because of the SARS-CoV-2 pandemic, there are several SARS-CoV-2 vaccines currently in late stage clinical trials, so the ACIP is now meeting monthly for single day meetings, with plans to continue standard 2-3 day meetings as per usual (February, June, and October). Emergency meetings of ACIP may occur if a vaccine candidate receives an Emergency Use Authorization (EUA) from the FDA. This Update provides a combined summary of the August 26 and September 22, 2020, meetings, both of which focused completely on COVID-19 vaccines. Representatives from the American Academy of Pediatrics (YAM, DWK) and the Pediatric Infectious Diseases Society (STO) are present as liaisons to the ACIP